1.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000651536, RTOG-0920, NCT00956007
|
|
2.
|
Phase: Phase III Type: Supportive care Status: Approved-not yet active Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000674208, MDA-04-01, 2010-0547, NCT01141231
|
|
3.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000706698, ANZGOG-0902-GOG-0274/RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
|
|
4.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000738944, RTOG-1203, NCT01672892
|
|
5.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: 2009-0517, NCT01219673
|
|
6.
|
Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 18 to 64 Sponsor: NCI, Other Protocol IDs: 2010-0557, R01 026582-26, NCT01330446
|
|
7.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000533887, RTOG-0526, NCT00450411
|
|
8.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CCCWFU 98110, U10CA081851, WFU-08-08-09, NCT01105130
|
|
9.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: 2010-0096, NCT01173692
|
|
10.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000690182, RTOG-1012, NCT01262560
|
|
11.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000703682, RTOG-1114, NCT01399372
|
|
12.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 3 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000734032, COG-ACNS1123, ACNS1123, NCT01602666
|
|
13.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 to 90 Sponsor: NCI Protocol IDs: 110129, 11-C-0129, NCT01324141
|
|
14.
|
Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 10-205, NCT01340495
|